Skip to main content
Livermore
Livermore
ZHEN

D.A. Davidson & Co.

SEC CIK
0001080107
Latest filing
Jul 24, 2026

REGN holding history

Regeneron Pharmaceuticals, Inc. in every 13F filed by D.A. Davidson & Co., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

REGN overviewAll 13F holders of REGNFull Q2 2026 holdings

Shares (Q2 2026)
554
Value
$345.4K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of REGN by D.A. Davidson & Co., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026554$345.4K<0.1%+29+5.5%AddedHolders
Q1 2026525$405.6K<0.1%−19−3.5%ReducedHolders
Q4 2025544$419.9K<0.1%−66−10.8%ReducedHolders
Q3 2025610$343.0K<0.1%+1+0.2%AddedHolders
Q2 2025609$319.7K<0.1%−123−16.8%ReducedHolders
Q1 2025732$464.3K<0.1%−21−2.8%ReducedHolders
Q4 2024753$536.4K<0.1%−68−8.3%ReducedHolders
Q3 2024821$863.1K<0.1%+40+5.1%AddedHolders
Q2 2024781$820.9K<0.1%+72+10.2%AddedHolders
Q1 2024709$682.4K<0.1%00.0%UnchangedHolders
Q4 2023709$622.7K<0.1%+103+17.0%AddedHolders
Q3 2023606$498.7K<0.1%−301−33.2%ReducedHolders
Q2 2023907$651.7K<0.1%−116−11.3%ReducedHolders
Q1 20231,023$840.6K<0.1%+439+75.2%AddedHolders
Q4 2022584$421.4K<0.1%−14−2.3%ReducedHolders
Q3 2022598$412.0K<0.1%+57+10.5%AddedHolders
Q2 2022541$320.0K<0.1%−15−2.7%ReducedHolders
Q1 2022556$388.0K<0.1%+58+11.6%AddedHolders
Q4 2021498$314.0K<0.1%+15+3.1%AddedHolders
Q3 2021483$292.0K<0.1%−20−4.0%ReducedHolders
Q2 2021503$281.0K<0.1%+42+9.1%AddedHolders
Q1 2021461$218.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.